CP-x Synthetic Cannabinoids Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 69 studies associated with CP-x Synthetic Cannabinoids.
Here is a small sampling of CP-x Synthetic Cannabinoids studies by title:
- Synthetic cannabinoid CP-55,940 induces apoptosis in a human skeletal muscle model via regulation of CB1 receptors and L-type Ca2+ channels
- Age-dependent hormesis-like effects of the synthetic cannabinoid CP55940 in C57BL/6 mice
- Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.
- Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells.
- On The Effects Of CP 55-940 And Other Cannabinoid Receptor Agonists In C6 And U373 Cell Lines
Components of the CP-x Synthetic Cannabinoids Research Dashboard
- Top medical conditions associated with CP-x Synthetic Cannabinoids
- Proven effects in clinical trials for CP-x Synthetic Cannabinoids
- Receptors associated with CP-x Synthetic Cannabinoids
- Individual study details for CP-x Synthetic Cannabinoids
Ready to become a subscriber? Go to our PRICING page.
Page Quick Links
Select New Cannabinoid
Overview - CP-x Synthetic Cannabinoids
Description of CP-x Synthetic Cannabinoids
The CP- class of synthetic cannabinoids are named after the company Carl Pfizer where they were first synthesized.CP-55,940 was discovered in 1974 and is one of the most studied member of this class.
The description in these text boxes highlight only the properties associated with CP-55,940
Other Names:
CP Family of Synthetic CannabinoidsCP55,940; CP-55,940; CP-55940 plus numerous supplier-based synonyms.
IUPAC Name: 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
Molecular Formula: C24H40O3
CP-x Synthetic Cannabinoids Properties and Effects
CP-55,940 may induce:• Apoptosis in human embryonic rhabdomyosarcoma cell line (Ken-Ichi Tomiyama et al., 2020).
• Apoptosis in glioblastoma cell lines i.e., C6 and U373 (A. Ortega et al., 2015).
• Analgesic effects following hypoxia reoxygenation with potential relevance to severe pain in sickle cell disease (David Cain et al., 2013).
• Reduction of SKF (dopamine D1 receptor agonist)-induced oral dyskinesia (Morten V Madsen et al., 2011).
CP-x Synthetic Cannabinoids Receptor Binding
Endocannabinoid System (ECS) and CP-55,940:• CB1 a mean Kd at 2.5nM (10 times more potent than THC).
• CB2 a mean Kd at 0.92nM (38 times more potent than THC).
Endocannabinoidome (eCBome) and CP-55,940:
• PPAR-Gamma (initiates anti-inflammatory response)
• GPR55
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
